Small molecule inhibitors of PARP activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8513433
APP PUB NO 20120184533A1
SERIAL NO

13381856

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and pharmaceutical compositions are provided that inhibit the activity of poly ADP-ribose synthetase (PARP). Such compounds are useful in the treatment of various diseases, conditions and injuries such as stroke, myocardial infarction, ischemia-perfusion injury in various organs, traumatic brain injury, atherosclerosis, inflammatory diseases and cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ANGION BIOMEDICA CORP51 CHARLES LINDBERGH BLVD UNIONDALE NY 11553

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lim, Dong Sung Rochelle Park, US 29 198
Panicker, Bijoy Holbrook, US 45 575
Smith, David E Sea Cliff, US 103 1409

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 20, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00